VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.3475
0.00 (0.00%)
At close: Aug 13, 2025, 4:00 PM
0.3400
-0.0075 (-2.16%)
Pre-market: Aug 14, 2025, 9:07 AM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $5.79 million as of August 14, 2025. Its market cap has decreased by -78.91% in one year.
Market Cap
5.79M
Enterprise Value
-44.42M
1-Year Change
-78.91%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $5.79M, a decrease of -97.48%. That is a compound annual growth rate of -49.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 5.79M | -88.28% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |